Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 14 de 14
Filtrer
Plus de filtres











Gamme d'année
1.
Med. oral patol. oral cir. bucal (Internet) ; 25(1): e29-e33, ene. 2020. ilus
Article de Anglais | IBECS | ID: ibc-196193

RÉSUMÉ

BACKGROUND: The aim of this research was to study anti-microbial and anti-inflammatory characteristics of silver nanoparticles helping bone structures to recover during late stage of parodontitis, which afterwards will increase the effect of bone regeneration operations. MATERIAL AND METHODS: We assessed colloid solution-derived silver nanoparticles coating of polylactic acid membrane regarding tissue foreign body response. Thirty eight polylactic acid membranes were implanted intracranially in rabbits ten unmodified (control group) and twenty eight with silver nanoparticles coating (experimental group). In controls, penicillin was used for infection prophylaxis. Tissue response was assessed by light microscopy and immunohistochemistry (CD3, CD15, CD30) 2 weeks after implantation. RESULTS: inflammation markers in experimental group were significantly lower than in control group, there were no signs of forming a fibrosis capsule nor infectious signs. CONCLUSIONS: colloid silver solution can be used as a source of nanoparticles for anti-microbial and antiinflammatory biodegradable membranes' coating


No disponible


Sujet(s)
Animaux , Mâle , Lapins , Nanoparticules métalliques/composition chimique , Argent/pharmacologie , Polyesters/pharmacologie , Anti-inflammatoires/pharmacologie , Anti-infectieux/pharmacologie , Os occipital/effets des médicaments et des substances chimiques , Polyesters/composition chimique , Argent/composition chimique , Anti-inflammatoires/composition chimique , Anti-infectieux/composition chimique , Immunohistochimie , Os occipital/anatomopathologie , Régénération osseuse/effets des médicaments et des substances chimiques , Reproductibilité des résultats
2.
Eur J Orthod ; 35(6): 826-31, 2013 Dec.
Article de Anglais | MEDLINE | ID: mdl-23172577

RÉSUMÉ

The aim of this study was to assess the effect of the flavonoid naringin on the growth of the spheno-occipital synchondrosis by quantifying the levels of expression of Sox9 and PTHrP in an in vitro mouse model. Fifty 1-day-old BALB/c mice were randomly assigned to experimental or control groups, and each group equally divided into five time frames (6, 24, 48, 72 and 168 hours). The mice were sacrificed with phenobarbitone sodium, and the spheno-occipital synchondroses dissected and cultured in control or experimental medium, with the experimental medium supplemented with 0.1 µm naringin. Sections of the specimens underwent immunohistochemical staining for Sox9 and PTHrP, and the amount of expression was quantified using true-colour RGB (red-green-blue) computer-assisted image-analysing system with digital imaging. Data analysis showed there was a significant increase of expression of Sox9 at 6 and 24 hours (P < 0.001) between experimental and control groups, however, there was no significant difference between the levels of expression of PTHrP between experimental and control groups at any of the time frames. There was a very weak correlation found in this study between the expression of PTHrP and Sox9. In conclusion, naringin enhances the growth of the spheno-occipital synchondrosis through over expression of Sox9. This is a successful in vitro model to study factors regulating the growth of the spheno-occipital synchondrosis.


Sujet(s)
Flavanones/pharmacologie , Os occipital/effets des médicaments et des substances chimiques , Protéine apparentée à l'hormone parathyroïdienne/métabolisme , Facteur de transcription SOX-9/métabolisme , Os sphénoïde/effets des médicaments et des substances chimiques , Animaux , Souris , Souris de lignée BALB C , Os occipital/croissance et développement , Os occipital/métabolisme , Os sphénoïde/croissance et développement , Os sphénoïde/métabolisme
3.
J Dent Res ; 92(1): 58-64, 2013 Jan.
Article de Anglais | MEDLINE | ID: mdl-23114031

RÉSUMÉ

C-type natriuretic peptide (CNP) is a potent stimulator of long bone and vertebral development via endochondral ossification. In the present study, we investigated the effects of CNP on craniofacial skeletogenesis, which consists of both endochondral and membranous ossification. Morphometric analyses of crania from CNP knockout and transgenic mice revealed that CNP stimulates longitudinal growth along the cranial length, but does not regulate cranial width. CNP markedly increased the length of spheno-occipital synchondrosis in fetal murine organ cultures, and the thickness of cultured murine chondrocytes from the spheno-occipital synchondrosis or nasal septum, resulting in the stimulation of longitudinal cranial growth. Mandibular growth includes endochondral and membranous ossification; although CNP stimulated endochondral bone growth of condylar cartilage in cultured fetal murine mandibles, differences in the lengths of the lower jaw between CNP knockout or transgenic mice and wild-type mice were smaller than those observed for the lengths of the upper jaw. These results indicate that CNP primarily stimulates endochondral ossification in the craniofacial region and is crucial for midfacial skeletogenesis.


Sujet(s)
Os de la face/effets des médicaments et des substances chimiques , Peptide natriurétique de type C/pharmacologie , Ostéogenèse/effets des médicaments et des substances chimiques , Crâne/effets des médicaments et des substances chimiques , Agrécanes/analyse , Animaux , Cartilage articulaire/effets des médicaments et des substances chimiques , Techniques de culture cellulaire , Prolifération cellulaire/effets des médicaments et des substances chimiques , Céphalométrie/méthodes , Chondrocytes/effets des médicaments et des substances chimiques , Collagène de type II/génétique , Collagène de type X/analyse , Sutures crâniennes/effets des médicaments et des substances chimiques , Relation dose-effet des médicaments , Imagerie tridimensionnelle/méthodes , Mandibule/effets des médicaments et des substances chimiques , Condyle mandibulaire/effets des médicaments et des substances chimiques , Maxillaire/effets des médicaments et des substances chimiques , Souris , Souris knockout , Souris transgéniques , Cartilages du nez/effets des médicaments et des substances chimiques , Os occipital/effets des médicaments et des substances chimiques , Techniques de culture d'organes , Antigène nucléaire de prolifération cellulaire/analyse , Base du crâne/effets des médicaments et des substances chimiques , Os sphénoïde/effets des médicaments et des substances chimiques , Microtomographie aux rayons X/méthodes
4.
Arch Oral Biol ; 57(9): 1225-30, 2012 Sep.
Article de Anglais | MEDLINE | ID: mdl-22386249

RÉSUMÉ

OBJECTIVE: Methionine is an essential amino acid and pivotal for normal growth and development. However, previous animal studies have shown that excessive maternal intake of methionine causes growth restrictions, organ damages, and abnormal growth of the mandible in newborn animals. However, the effect of excessive methionine on the development of the cranial growth plate is unknown. This study investigated histological alterations of the cranial growth plate induced by high methionine administration in newborn rats. DESIGN: Twenty pregnant dams were divided into a control and an experimental group. The controls received a diet for rats and the experimental group was fed from the 18th gestational day with a special manufactured high methionine diet for rats. The high methionine diet was maintained until the end of the lactation phase (day 20). The offspring of both groups were killed at day 10 or 20 postnatally and their spheno-occipital synchondroses were collected for histological analysis. RESULTS: The weight of the high-dose methionine treated experimental group was considerably reduced in comparison to the control group at day 10 and 20 postnatally. The cartilaginous area of the growth plate and the height of the proliferative zone were markedly reduced at postnatal day 10 in the experimental group. CONCLUSIONS: In summary, the diet-induced hypermethioninemia in rat dams resulted in growth retardations and histomorphological changes of the spheno-occipital synchondrosis, an important craniofacial growth centre in newborns. This finding may elucidate facial dysmorphoses reported in patients suffering from hypermethioninemia.


Sujet(s)
Sutures crâniennes/effets des médicaments et des substances chimiques , Méthionine/effets indésirables , Effets différés de l'exposition prénatale à des facteurs de risque , Animaux , Animaux nouveau-nés , Poids/effets des médicaments et des substances chimiques , Développement osseux/effets des médicaments et des substances chimiques , Cellules de la moelle osseuse/effets des médicaments et des substances chimiques , Cellules de la moelle osseuse/anatomopathologie , Calcification physiologique/effets des médicaments et des substances chimiques , Cartilage/effets des médicaments et des substances chimiques , Cartilage/anatomopathologie , Prolifération cellulaire/effets des médicaments et des substances chimiques , Chondrocytes/effets des médicaments et des substances chimiques , Chondrocytes/anatomopathologie , Sutures crâniennes/croissance et développement , Sutures crâniennes/anatomopathologie , Femelle , Cartilage hyalin/effets des médicaments et des substances chimiques , Cartilage hyalin/anatomopathologie , Traitement d'image par ordinateur/méthodes , Mâle , Os occipital/effets des médicaments et des substances chimiques , Os occipital/croissance et développement , Grossesse , Répartition aléatoire , Rats , Rats de lignée LEW , Os sphénoïde/effets des médicaments et des substances chimiques , Os sphénoïde/croissance et développement , Os sphénoïde/anatomopathologie , Facteurs temps
5.
Eur J Orthod ; 34(2): 133-40, 2012 Apr.
Article de Anglais | MEDLINE | ID: mdl-21808074

RÉSUMÉ

This investigation examined the effects of pharmacologically induced precocious puberty on cranial growth in Wistar rats. Forty-eight female newborn Wistar rats were divided into two groups: a control group (C) and an experimental group (E), with four subgroups of six animals each. The time interval from birth until sacrifice differed between the subgroups, and was set at 30, 60, 90, and 120 days. An intramuscular single dose (300 µg) of steroid hormone danazol was administered on day 5 after birth, as a means of inducing precocious puberty. Alizarin (2 mg/100 g) was administered to three animals in each subgroup three days prior to sacrifice. Body mass and dates corresponding to the beginning of the oestrous cycle were recorded. Craniometric measurements were undertaken. Histological analysis using light and fluorescence microscopy was then carried out to qualitatively and quantitatively evaluate the spheno-occipital synchondrosis and to visualize bone deposition patterns. The results were analysed with a Student's t-test and analysis of variance. Precocious puberty was effectively induced and differences between groups denoted an earlier maturation in the experimental rats. In qualitative analysis, a significant increase of total synchondrosis width was noted only in group E60, in comparison with C60, and an increase in the E90 subgroup cortical bone width compared with the C90 subgroup. Histomorphometrically, a statistical difference between total width values of subgroups E60 (434.3 µm) and C60 (323.5 µm) was detected. However, body mass and macroscopic measurements did not show statistically significant differences. An appropriate model for studying bone growth associated with precocious puberty in Wistar female rats was not achieved using steroid hormone danazol, when evaluated at 30 day intervals.


Sujet(s)
Puberté précoce/physiopathologie , Crâne/croissance et développement , Animaux , Animaux nouveau-nés , Anthraquinones , Composition corporelle/effets des médicaments et des substances chimiques , Moelle osseuse/effets des médicaments et des substances chimiques , Moelle osseuse/anatomopathologie , Calcification physiologique/effets des médicaments et des substances chimiques , Cartilage/effets des médicaments et des substances chimiques , Cartilage/croissance et développement , Céphalométrie/méthodes , Chondrocytes/effets des médicaments et des substances chimiques , Chondrocytes/anatomopathologie , Agents colorants , Sutures crâniennes/effets des médicaments et des substances chimiques , Sutures crâniennes/croissance et développement , Danazol/effets indésirables , Antagonistes des oestrogènes/effets indésirables , Cycle oestral/effets des médicaments et des substances chimiques , Femelle , Microscopie de fluorescence , Os nasal/effets des médicaments et des substances chimiques , Os nasal/croissance et développement , Os occipital/effets des médicaments et des substances chimiques , Os occipital/croissance et développement , Os pariétal/effets des médicaments et des substances chimiques , Os pariétal/croissance et développement , Puberté précoce/induit chimiquement , Rats , Rat Wistar , Crâne/effets des médicaments et des substances chimiques , Os sphénoïde/effets des médicaments et des substances chimiques , Os sphénoïde/croissance et développement , Facteurs temps
6.
Angle Orthod ; 82(2): 247-53, 2012 Mar.
Article de Anglais | MEDLINE | ID: mdl-21932938

RÉSUMÉ

OBJECTIVE: To identify the expressions of SOX9 and type II collagen in spheno-occipital synchondrosis in response to quercetin, using a mouse in vitro model. MATERIALS AND METHODS: A total of 50 one-day-old male BALB/c mice were randomly assigned to the control and experimental groups. Each group was subdivided into five different time points, which were 6, 24, 48, 72, and 168 hours, and each subgroup contained 5 mice (n  =  5). In the experimental group, the spheno-occipital synchondrosis was immersed in the BGJb medium + quercetin dihydrate 1 µM. In the control group, the spheno-occipital synchondrosis was immersed in the BGJb medium. Tissue sections were subjected to immunohistochemical staining for SOX9 and type II collagen expressions. RESULTS: Quantitative analysis revealed there was a statistically significant increase of 32.31% (P < .001) in the expression of SOX9 between experimental groups and control groups at 24 hours. Furthermore, there was a statistically significant increase of 22.99% (P < .001) in the expression of type II collagen between experimental groups and control groups at 72 hours. CONCLUSION: The expressions of SOX9 and type II collagen in the spheno-occipital synchondrosis can be increased by quercetin.


Sujet(s)
Antioxydants/pharmacologie , Collagène de type II/effets des médicaments et des substances chimiques , Sutures crâniennes/effets des médicaments et des substances chimiques , Os occipital/effets des médicaments et des substances chimiques , Quercétine/pharmacologie , Facteur de transcription SOX-9/effets des médicaments et des substances chimiques , Os sphénoïde/effets des médicaments et des substances chimiques , Animaux , Prolifération cellulaire , Chondrocytes/effets des médicaments et des substances chimiques , Chondrocytes/anatomopathologie , Immunohistochimie , Mâle , Souris , Souris de lignée BALB C , Techniques de culture d'organes , Répartition aléatoire , Facteurs temps
7.
Headache ; 49(1): 130-1, 2009 Jan.
Article de Anglais | MEDLINE | ID: mdl-18834455

RÉSUMÉ

We present a male with headache related to sexual activity. An injection of steroid and local anesthetic combination was applied to the greater occipital nerve of the symptomatic site. The orgasmic headache stopped after the procedure.


Sujet(s)
Anesthésiques locaux/usage thérapeutique , Anti-inflammatoires/usage thérapeutique , Céphalée/chirurgie , Méthylprednisolone/usage thérapeutique , Bloc nerveux , Orgasme , Prilocaïne/usage thérapeutique , Adulte , Céphalée/étiologie , Humains , Mâle , Os occipital/effets des médicaments et des substances chimiques , Os occipital/innervation
8.
Stomatologiia (Mosk) ; 87(3): 4-8, 2008.
Article de Russe | MEDLINE | ID: mdl-18577914

RÉSUMÉ

In rat experiments the ability of noncollagen bone proteins (NCBP) in the composition of osteoplactic modified material Gapkol (not tanned in formalin and subjected to vacuum extraction) to increase bone reparation in comparison with traditional Gapkol was studied. Quantitative evaluation was performed on rat parietal bone and qualitative evaluation was performed on rat mandible. It was shown that Gapkol with NCBP (not tanned in formalin and subjected to vacuum extraction) increased reparative osteogenesis.


Sujet(s)
Substituts osseux/administration et posologie , Os et tissu osseux/composition chimique , Collagène/pharmacologie , Durapatite/pharmacologie , Protéines et peptides de signalisation intercellulaire/physiologie , Mandibule/effets des médicaments et des substances chimiques , Ostéogenèse/physiologie , Protéines/analyse , Vide , Animaux , Protéines morphogénétiques osseuses/métabolisme , Calcification physiologique/physiologie , Collagène/administration et posologie , Association médicamenteuse , Durapatite/administration et posologie , Inlays , Mâle , Mandibule/métabolisme , Os occipital/effets des médicaments et des substances chimiques , Os occipital/métabolisme , Rats , Rat Wistar
9.
Neurochirurgie ; 52(1): 57-62, 2006 Feb.
Article de Français | MEDLINE | ID: mdl-16609661

RÉSUMÉ

STUDY DESIGN: First published report of a cranial aneurysmal bone cyst (ABC) treated successfully with intralesional injection of calcitonin. OBJECTIVES: To describe a safe and effective treatment method for ABCs of the cranial base. SUMMARY OF BACKGROUND DATA: ABC is a rare form of dystrophic pseudotumor. Less than 100 cases involving the skull have been reported in the literature, most of them localised in the cranial vault. Cranial base locations are rare and difficult to treat. We selected this treatment after a very rapid recurrence of the lesion following a partial resection. Method. - After a partial resection of a 10 cm petro-occipital ABC that encased the vertebral artery and the lower cranial nerves, an Ommaya reservoir was implanted with a catheter tip inside the ABC. Repeated intralesional injections of calcitonin were performed through the reservoir. RESULTS: Shrinkage of the cyst occurred with disappearance of its heterogeneous cystic content and ossification of its walls. There was no complication and the lesion remains quiescent at a 3 year follow-up. CONCLUSION: We reviewed the pertinent literature concerning percutaneous treatment of ABC. The percutaneous intralesionnal injection of calcitonin was reported in the literature only in 3 publications reporting 9 cases that did not involve the skull. This treatment seems safe and effective, worthy in cranial base ABCs that are difficult to resect completely.


Sujet(s)
Kystes osseux anévrismaux/chirurgie , Calcitonine/administration et posologie , Os occipital/chirurgie , Rocher/chirurgie , Complications postopératoires/chirurgie , Adolescent , Kystes osseux anévrismaux/diagnostic , Kystes osseux anévrismaux/anatomopathologie , Cathéters à demeure , Association thérapeutique , Femelle , Humains , Injections intralésionnelles , Imagerie par résonance magnétique , Examen neurologique , Os occipital/effets des médicaments et des substances chimiques , Os occipital/anatomopathologie , Rocher/effets des médicaments et des substances chimiques , Rocher/anatomopathologie , Complications postopératoires/diagnostic , Complications postopératoires/anatomopathologie , Récidive , Réintervention , Tomodensitométrie
12.
Acta Anat (Basel) ; 97(3): 300-6, 1977.
Article de Anglais | MEDLINE | ID: mdl-855632

RÉSUMÉ

Methylazoxymethanol (MAM) causes a reduced development of cerebellum and medulla oblongata in rats. To study the effect of external factors on growth of the spheno-occipital synchondrosis, four litters of rats each of five animals were treated with MAM within 12 h after birth and sacrificed after 30 days. A similar number od control rats were sacrificed at the time when their skull length was equal to that of the experimental rats. Microradiographical and histological investigations showed that the cranial base lordosis was more pronounced in the MAM rats than in the controls, and that the width of the spheno-occipital synchondrosis was reduced mainly due to reduction in the central zone.


Sujet(s)
Composés azoïques/pharmacologie , Acétate de méthyl-ONN-azoxy-méthyle/pharmacologie , Os occipital/croissance et développement , Os sphénoïde/croissance et développement , Animaux , Cervelet/croissance et développement , Moelle allongée/effets des médicaments et des substances chimiques , Moelle allongée/croissance et développement , Os occipital/effets des médicaments et des substances chimiques , Rats , Os sphénoïde/effets des médicaments et des substances chimiques
13.
Birth Defects Orig Artic Ser ; 11(7): 283-95, 1975.
Article de Anglais | MEDLINE | ID: mdl-1212507

RÉSUMÉ

Additional experimental data indicate that cranial base elongation is secondarily responsive to prior alterations of the neural mass, further supporting the functional matrix concept. Additional studies of epithelial growth and of muscle regeneration suggest that neurotrophic processes, regulating functional matrices, may play a significant role in both normal and abnormal cephalogenesis.


Sujet(s)
Crâne/croissance et développement , Animaux , Encéphale/croissance et développement , Cartilage/croissance et développement , Cervelet/malformations , Oreille externe/croissance et développement , Muscles de la face/croissance et développement , Développement maxillofacial , Souris , Motoneurones/physiologie , Développement musculaire , Mutagènes/pharmacologie , Mutation , Neurones afférents/physiologie , Neurones efférents/physiologie , Os occipital/effets des médicaments et des substances chimiques , Rats
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE